Kailera Therapeutics, Inc.

NASDAQ:KLRA

Biotechnology

Healthcare
$11.79 +2.66%

+$0.51 today

Market cap
$1.53B
Beta
0.00
52W Low $18.50High $28.23

Volume 0.42M

Average 0.80M

Price history

Kailera Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-54.65%

Period high

$26.00

Period low

$10.00

Latest

$11.79

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 4, 2026Nov 4, 2026
8-KNov 4, 2026Nov 4, 2026
4Sep 9, 2026Sep 9, 2026
3Sep 9, 2026Sep 9, 2026
SC 13GAug 14, 2026Aug 14, 2026
SC 13GAug 14, 2026Aug 14, 2026
10-QAug 12, 2026Aug 12, 2026
8-KAug 12, 2026Aug 12, 2026
SC 13GAug 5, 2026Aug 5, 2026
4Jul 8, 2026Jul 8, 2026
3Jul 8, 2026Jul 8, 2026
4Jun 11, 2026Jun 11, 2026
10-QMay 26, 2026May 26, 2026
8-KMay 26, 2026May 26, 2026
SC 13DApr 23, 2026Apr 23, 2026

Competitors

Who does Kailera Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about KLRA's filings, answered from its disclosures.

What is the latest KLRA filing?

The latest filing shown is 8-K dated Nov 4, 2026.

How many recent filings does KLRA have?

Intrinsic Alpha currently shows 20 recent filings for KLRA.